Alzeca Biosciences Alternatives & Competitors

12 companies similar to Alzeca Biosciences

Satoris Inc.

3 Series B $5.20M

Menlo Park, United States

Biotechnology Health Care +2

ENDRA Life Sciences (Nasdaq: NDRA)

Focused on early detection of liver disease

25 Post-IPO Equity $8.99M

Ann Arbor, United States

Biotechnology Health Care +1

NeuCyte

Decoding CNS Drug Discovery with SynFire® iP

11 Series A $6.70M

Mountain View, United Sta...

Biotechnology Health Care +2

Biscayne Neurotherapeutics Inc

A clinical-stage biotechnology company advancing innovative therapies for challenging neur...

2-10 Series B $3.00M

Miami, United States

Biotechnology Health Care +2

Rival Readout

Competing with Alzeca Biosciences? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Reven Pharmaceuticals

Diligently pursuing scientific innovation to exponentially improve health and well-being.

14 Series D

Westminster, United State...

Biotechnology Health Care +2

Athersys

Committed to developing therapies to extend and enhance the quality of life.

37 Post-IPO Equity $208.90M

Cleveland, United States

Biopharma Biotechnology +2

Allyx Therapeutics

Protecting Synapses and Reversing Neurodegeneration

5 Venture round $10.12M

New Haven, United States

Biotechnology Health Care +1

hVIVO

A rapidly growing early-stage Contract Research Organisation (CRO) and the global leader i...

248 Series B $2.60M

London, United Kingdom

Biotechnology Health Care

Quanterix

Powering Biomarkers from Discovery to Diagnostics

503 IPO $556.80M

Billerica, United States

Biotechnology Health Care +2

CNS Therapeutics

Delivering advanced neurological and pain treatments with precision and expertise

4 Venture round $10.05M

Saint Paul, United States

Biotechnology Health Care

InterCure

Harness the power of respiratory-based treatment for hypertension and heart failure with i...

Post-IPO Equity $41.90M

Biotechnology Health Care +3

Drive Therapeutics

Addressing Unmet Needs in Retinal Therapeutics

3 Grant $431.00K

United States

Biotechnology Health Care +1

About Alzeca Biosciences

Alzeca Biosciences is a biotechnology startup based in the United States, founded in 2012. The company's focus is on the early detection of Alzheimer's Disease pathology, a crucial need considering the projected quadrupling of Alzheimer's cases by 2050. With the disease pathology beginning to accumulate years prior to...

Business keywords

Alzheimers Disease, Early Detection, Imaging Technologies, Clinical Trials, Mild Cognitive Impairment, Drug Development, Scientific Advisory Board, Biomedical Technology

Frequently Asked Questions

Companies similar to Alzeca Biosciences include Satoris Inc., ENDRA Life Sciences (Nasdaq: NDRA), NeuCyte, Biscayne Neurotherapeutics Inc, Reven Pharmaceuticals. They work in Biotechnology and Health Care and share Alzeca Biosciences's focus on drug development, clinical trials and scientific advisory board.

Bounce Watch lists 12 companies that share Alzeca Biosciences's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Alzeca Biosciences: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Alzeca Biosciences Profile Satoris Inc. Alternatives ENDRA Life Sciences (Nasdaq: NDRA) Alternatives NeuCyte Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Alzeca Biosciences on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.